These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28589491)

  • 1. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.
    Bartucci M; Hussein MS; Huselid E; Flaherty K; Patrizii M; Laddha SV; Kui C; Bigos RA; Gilleran JA; El Ansary MMS; Awad MAM; Kimball SD; Augeri DJ; Sabaawy HE
    Target Oncol; 2017 Aug; 12(4):449-462. PubMed ID: 28589491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules.
    Yang T; Chen Y; Zhao P; Xue H; You J; Li B; Liu Y; He C; Zhang X; Fan L; Lee RJ; Li L; Ma X; Xu C; Xiang G
    Nanomedicine; 2018 Oct; 14(7):2009-2021. PubMed ID: 29842934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
    Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
    Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethyl acetate extract from Jiedu Xiaozheng Yin inhibits the proliferation of human hepatocellular carcinoma cells by suppressing polycomb gene product Bmi1 and Wnt/β-catenin signaling.
    Chen XZ; Cao ZY; Li JN; Hu HX; Zhang YQ; Huang YM; Liu ZZ; Hu D; Liao LM; Du J
    Oncol Rep; 2014 Dec; 32(6):2710-8. PubMed ID: 25333742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
    J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
    Qi S; Li B; Yang T; Liu Y; Cao S; He X; Zhang P; Li L; Xu C
    Int J Mol Sci; 2014 Nov; 15(11):20004-21. PubMed ID: 25372945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of BMI1 Promoter Inhibitors from Beaumontia murtonii and Eugenia operculata.
    Kaneta Y; Arai MA; Ishikawa N; Toume K; Koyano T; Kowithayakorn T; Chiba T; Iwama A; Ishibashi M
    J Nat Prod; 2017 Jun; 80(6):1853-1859. PubMed ID: 28598616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Bmi‑1 promotes epithelial‑mesenchymal transition in CD133+Hep G2 cells.
    Zhang Z; Wang Q; Bu X; Zhang C; Chen H; Sha W; Liu W
    Mol Med Rep; 2017 Nov; 16(5):6156-6161. PubMed ID: 28849237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.